Description
prada trial, The primary outcome measure of the PRADA II trial is the change in left ventricular ejection fraction (LVEF) by CMR from baseline to 18 months. Secondary outcomes include .
Beige and white GG Supreme canvas
Prada cardioprotection
Gold-toned hardware
Prada breast cancer treatment
Double G
Inside: 9 open pocket
Prada cardioprotection
Chain top handle with 7″ drop
Top zip closure
5.7″W x 4.6″H x 1.8″D
Weight: 0.1lbs approximately